Real-World Effectiveness and Safety Outcomes of Acalabrutinib Treatment By Line of Therapy in Patients with Chronic Lymphocytic Leukemia and/or Small Lymphocytic Lymphoma

被引：0
|
作者：
Jacobs, Ryan W. [1 ]
Teschemaker, Anna [2 ]
Hakre, Shweta [2 ]
Tian, Hongping [3 ]
Pyrih, Nick [3 ]
Wahlstrom, Svea K. [4 ]
Cui, Lianzhou [3 ]
机构：
[1] Atrium Hlth Levine Canc Inst, Charlotte, NC USA
[2] AstraZeneca, Gaithersburg, MD USA
[3] Cobbs Creek Hlth Care, Newtown Sq, PA USA
[4] AstraZeneca, Wilmington, DE USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-174974
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Real-World Characterization of Ibrutinib Therapy for Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL) Patients in British Columbia (BC)
    Khelifi, Rania S.
    Huang, Steven J. T.
    Savage, Kerry J.
    Villa, Diego
    Scott, David W.
    Ramadan, Khaled
    Connors, Joseph M.
    Sehn, Laurie H.
    Toze, Cynthia L.
    Gerrie, Alina S.
    BLOOD, 2020, 136
  • [22] Real-world time to discontinuation of first-line venetoclax plus obinutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina P.
    Wu, Linda H.
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Rogers, Kerry A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023, : 1227 - 1235
  • [23] Real-world time to discontinuation of first-line venetoclax plus binutuzumab in chronic lymphocytic leukemia/small lymphocytic lymphoma
    Lu, Xiaoxiao
    Emond, Bruno
    Qureshi, Zaina P.
    Wu, Linda H.
    Forbes, Shaun P.
    Hilts, Annalise
    Liu, Stephanie
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    Huang, Qing
    Rogers, Kerry A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2023,
  • [24] Real-world outcomes of venetoclax and rituximab for chronic lymphocytic leukemia/small lymphocytic lymphoma: A retrospective analysis of nine Japanese cases
    Saburi, Masuho
    Nishikawa, Takumi
    Miyazaki, Yasuhiko
    Kohno, Kazuhiro
    Sakata, Masanori
    Okuhiro, Kazuki
    Nakayama, Toshiyuki
    Ohtsuka, Eiichi
    Ogata, Masao
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2024, 64 (02) : 152 - 155
  • [25] Real-World Treatment Outcomes in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Were Treated With First-Line Single-Agent Ibrutinib vs Chemoimmunotherapy
    Wang, Ruibin
    Ding, Zhijie
    Lu, Xiaoxiao
    Mavani, Heena
    He, Jinghua
    Qureshi, Zaina
    Pinilla, Javier
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S330 - S330
  • [26] Real-world treatment outcomes in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who were treated with first-line single-agent ibrutinib vs chemoimmunotherapy
    Wang, Ruibin
    Ding, Zhijie
    Lu, Xiaoxiao
    Mavani, Heena
    He, Jinghua
    Qureshi, Zaina
    Pinilla, Javier
    LEUKEMIA & LYMPHOMA, 2023, 64 : S170 - S170
  • [27] Real-world effectiveness and safety of ibrutinib in patients with chronic lymphocytic leukemia in Japan: the Orbit study
    Muta, Tsuyoshi
    Masamoto, Yosuke
    Yamamoto, Go
    Kurahashi, Shingo
    Kameoka, Yoshihiro
    Ota, Shuichi
    Matsuki, Eri
    Ozeki, Kazutaka
    Toyama, Takanori
    Takahashi, Naoki
    Kumode, Takahiro
    Aotsuka, Nobuyuki
    Yoshimura, Takuro
    Tamura, Hideto
    Omi, Ai
    Shibayama, Kazuhiro
    Watanabe, Aki
    Isobe, Yasushi
    Kojima, Kensuke
    Takizawa, Jun
    Nagai, Hirokazu
    Suzumiya, Junji
    Aoki, Sadao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, : 161 - 173
  • [28] Treatment sequencing and outcomes in patients with chronic lymphocytic leukemia: the informCLL™ real-world registry
    Mato, Anthony
    Ghosh, Nilanjan
    Barrientos, Jacqueline
    Brander, Danielle
    Pagel, John
    Gutierrez, Meghan
    Kadish, Karen
    Tomlinson, Brian
    Ipe, David
    Sundaram, Murali
    Han, Jennifer
    Amaya-Chanaga, Carlos
    Iyengar, Reethi
    Sharman, Jeff
    LEUKEMIA & LYMPHOMA, 2020, 61 : 33 - 36
  • [29] Real-World Patterns of Targeted Therapy Use in Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma in the United States: A Longitudinal Study
    De Nigris, Enrico
    Cheng, Wendy Y.
    Sarpong, Eric M.
    Leng, Siyang
    Farooqui, Mohammed Z. H.
    Agu, Uchechukwu Samuel
    Catillon, Maryaline
    Lejeune, Dominique
    Downes, Nathaniel
    Matay, Lisa
    Duh, Mei Sheng
    Huntington, Scott F.
    BLOOD, 2023, 142
  • [30] Real-World Treatment Patterns and Outcomes by Line of Therapy and Race in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated in the United States: Results From the Final Analysis of the Prospective, Observational, informCLL Registry
    Ghosh, Nilanjan
    Sharman, Jeff P.
    Gutierrez, Meghan
    Khan, Wasiulla
    Qureshi, Zaina P.
    Raz, Anat
    Girardi, Vincent
    Krigsfeld, Gabriel S.
    Barrientos, Jacqueline C.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (09): : e301 - e313
12345